Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Steensma

Showing results (11-20 of 456) with videos related to

Pageof 46
Sort By:
Annals of Internal Medicine|June 18, 2003
The In-Training Examination in Internal MedicineDavid P Steensma
Annals of Internal Medicine|May 4, 2006
Working against the grainDavid P Steensma
Best Practice & Research. Clinical Haematology|December 4, 2012
Can hypomethylating agents provide a platform for curative therapy in myelodysplastic syndromes?David P Steensma
Best Practice & Research. Clinical Haematology|November 21, 2017
The evolving role of genomic testing in assessing prognosis of patients with myelodysplastic syndromesDavid P Steensma
The Lancet. Oncology|April 1, 2008
A premature obituary for erythropoietin analoguesDavid P Steensma
Mayo Clinic Proceedings|September 4, 2024
Six Centuries of Raeapteek in Estonia: The Oldest Surviving Pharmacy Still Open to the PublicDavid P Steensma
Leukemia Research|August 28, 2012
Historical perspectives on myelodysplastic syndromesDavid P Steensma
Blood|March 21, 2015
Speaking a common language in MDS/MPNsDavid P Steensma
Mayo Clinic Proceedings|July 3, 2025
The US Narcotic Tax Revenue StampsDavid P Steensma
British Journal of Haematology|December 3, 2023
Revisiting the first reported case of aplastic anaemiaDavid P Steensma
Pageof 46

Showing results (11-20 of 456) with videos related to

Sort By:
Pageof 46
Annals of Internal Medicine|June 18, 2003
The In-Training Examination in Internal MedicineDavid P Steensma
Annals of Internal Medicine|May 4, 2006
Working against the grainDavid P Steensma
Best Practice & Research. Clinical Haematology|December 4, 2012
Can hypomethylating agents provide a platform for curative therapy in myelodysplastic syndromes?David P Steensma
Best Practice & Research. Clinical Haematology|November 21, 2017
The evolving role of genomic testing in assessing prognosis of patients with myelodysplastic syndromesDavid P Steensma
The Lancet. Oncology|April 1, 2008
A premature obituary for erythropoietin analoguesDavid P Steensma
Mayo Clinic Proceedings|September 4, 2024
Six Centuries of Raeapteek in Estonia: The Oldest Surviving Pharmacy Still Open to the PublicDavid P Steensma
Leukemia Research|August 28, 2012
Historical perspectives on myelodysplastic syndromesDavid P Steensma
Blood|March 21, 2015
Speaking a common language in MDS/MPNsDavid P Steensma
Mayo Clinic Proceedings|July 3, 2025
The US Narcotic Tax Revenue StampsDavid P Steensma
British Journal of Haematology|December 3, 2023
Revisiting the first reported case of aplastic anaemiaDavid P Steensma
Pageof 46